Home > National Drug Code (NDC) > Treatment Set TS340796

Treatment Set TS340796 - 49288-0811-3 - (Treatment Set TS340796)

Alphabetical Index


Drug Information Labeler Information Package Information NDC Record

Drug Information of Treatment Set TS340796

Product NDC: 49288-0811
Proprietary Name: Treatment Set TS340796
Non Proprietary Name: Treatment Set TS340796
Active Ingredient(s): .002; .001; .001; 400; 400; 400; .002; .002; 4000    g/mL; g/mL; g/mL; [BAU]/mL; [AU]/mL; [AU]/mL; g/mL; g/mL; g/mL & nbsp;   Treatment Set TS340796
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS340796

Product NDC: 49288-0811
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS340796

Package NDC: 49288-0811-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0811-3)

NDC Information of Treatment Set TS340796

NDC Code 49288-0811-3
Proprietary Name Treatment Set TS340796
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0811-3)
Product NDC 49288-0811
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS340796
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name AMARANTHUS RETROFLEXUS POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA TOMENTOSA POLLEN; CYNODON DACTYLON POLLEN; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; JUGLANS NIGRA POLLEN; PERIPLANETA AMERICANA; PHLEUM PRATENSE POLLEN
Strength Number .002; .001; .001; 400; 400; 400; .002; .002; 4000
Strength Unit g/mL; g/mL; g/mL; [BAU]/mL; [AU]/mL; [AU]/mL; g/mL; g/mL; g/mL
Pharmaceutical Classes Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS340796


Featured Tools

NDC Directory

Pill Identifier

Latest Updates

FDA Consumer Updates Drug Recalls Medwatch Safety Alerts

General Information

Medical Words Medical Acronyms
© 2024 - Pharmaguru.com. All rights reserved.